Elevance Health Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Gail Koziara Boudreaux
- Full Time Employees
- 104,200
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Address
- 220 Virginia Avenue Indianapolis IN United States of America 46204
- IPO Date
- Oct 30, 2001
- CIK
- 0001156039
- Website
- elevancehealth.com
- Similar Companies
- Business
- Elevance Health Inc. (NYSE: ELV) operates as a leading health benefits company in the United States, providing a comprehensive portfolio of medical, dental, vision, pharmaceutical, behavioral health, long-term care, disability, and life insurance plans through affiliated brands including Anthem Blue Cross and Blue Shield in 14 states, Wellpoint Medicaid plans, Carelon services, Amerigroup, and others; it also delivers advanced healthcare solutions such as pharmacy benefit management via CarelonRx, clinical care coordination, digital health tools, primary care enablement, and whole-person care addressing social drivers of health. Headquartered in Indianapolis, Indiana, the company traces its origins to 1946 through predecessor entities like Anthem and WellPoint, which merged in 2004, and rebranded from Anthem Inc. to Elevance Health in June 2022 to reflect its focus on elevating health outcomes. Elevance Health serves approximately 47 million medical members nationwide, with operations spanning commercial employer-sponsored plans, individual coverage, Medicare Advantage, and Medicaid programs across multiple states including California, Florida, Georgia, Indiana, Kentucky, Missouri, New York, Ohio, Texas, and Puerto Rico via subsidiaries like MMM; it targets employers, individuals, families, government programs, and complex-needs populations through segments encompassing Health Benefits, CarelonRx, Carelon Services, and other corporate activities. The company has pursued aggressive expansion in specialty care and home-based services, including the 2024 acquisition of Paragon Healthcare for infusion therapies and CareBridge for home health management; it acquired Kroger Specialty Pharmacy in 2024 to bolster CarelonRx's infusion and mail-order capabilities, alongside earlier purchases of BioPlus Specialty Pharmacy and opening new dispensing centers. In April 2024, Elevance Health formed a strategic partnership with Clayton, Dubilier & Rice, integrating Carelon Health assets with apree health and Millennium Physician Group to innovate primary care delivery across U.S. regions. Recent initiatives encompass expanding behavioral health interventions and external partnerships under Carelon to manage medical costs, deepening AI integrations via a partnership with OpenAI announced in Q3 2025, scaling pharmacy home delivery and specialty services, enhancing Star ratings through member engagement, and broadening access to doula care and histotripsy treatments for liver tumors for over 45 million members; the company also rebranded Amerigroup to Wellpoint in 2024 and continues investing in digital automation and value-based care principles to drive long-term growth amid Medicaid dynamics.
Elevance Tops $1B in Housing Investments: What's Driving the Strategy?
The Healthcare M&A Wave
Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide
Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide
ELV DCF Analysis: Intrinsic Value $643 vs Price $402
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?
Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support
Elevance Health, Inc. (ELV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue?
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers
Is ELV Undervalued? DCF Says Worth $643
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
A Look at Elevance Health Inc (ELV) After 4.0% Gain -- GF Value $518.29 vs Price $393.30
Is ELV Undervalued? DCF Says Worth $643
Is ELV Undervalued? DCF Says Worth $643
Major health insurers show signs of recovery – but a key test looms
This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how